Skip to main content

Table 1 Relationship between CDK16 expression and clinicopathologic parameters of HCC patients

From: RETRACTED ARTICLE: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression

Characteristics

Number of cases

CDK16 expression

p value

Low (n = 36)

High (n = 36)

Age (years)

   

0.339

  ≥ 65

42

19

23

 

  < 65

30

17

13

 

Gender

   

0.234

 Male

58

27

31

 

 Female

14

9

5

 

Tumor size

   

0.077

  ≥ 5 cm

49

21

28

 

  < 5 cm

23

15

8

 

Edmondson Grade

   

0.023*

 I-II

57

31

26

 

 III-IV

20

5

15

 

Encapsulation

   

0.020*

 Yes

51

30

21

 

 No

21

6

15

 

Tumor number

   

0.042*

 Singular

57

32

25

 

 Multifocal

15

4

11

 

HBV infection

   

0.781

 Positive

55

27

28

 

 Negtive

17

9

8

 

BCLC stage

   

0.107

 A

57

32

28

 

 B and C

10

2

8

 

Cirrhosis

   

0.800

 Yes

49

24

25

 

 No

23

12

11

 

Serum AFP(μg/L)

   

0.437

  ≥ 400

51

27

24

 

  < 400

21

9

12

 

PVTT

   

0.029*

 Yes

9

1

8

 

 No

63

35

27

 
  1. BCLC Barcelona Clinic Liver Cancer
  2. PVTT portal vein tumor thrombus
  3. * P < 0.05